Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy

Andrew Spencer, MBBS, FRACP, FRCPA, DM, Hang Quach, MD FRACP, FRCPA, MBBS, Noemi Horvath, MBBS FRACP FRCPA, Ian H. Kerridge, FRACP, FRCPA, MPhil, BA, Flora Yuen, BBiomedSc, Edwin Sze-Hung Lee, MD FRACP, FRCP, FRCPA, FRCPath, Edward S. Morris, BMBS, DM, Anna Kalff, MBBS, Krystal Bergin, Shreerang Sirdesai, MBBS, FRACP, FRCPA, Malgorzata Gorniak, BSc, Sridurga Mithraprabhu, PhD MSc, Tiffany Khong, BSc, PhD, John Reynolds, PhD

Blood (2018) 132 (Supplement 1): 3279.

https://doi.org/10.1182/blood-2018-99-113982

Published: 2018

Journal Articles

Prostaglandin I 2 in the Endosteal Bone Marrow Niche As a Novel Regulator of Hematopoietic Stem Cells

Joshua Tay, PhD, Jean-Pierre Levesque, PhD, Falak Helwani, PhD, Gareth Price, PhD, Bianca Nowlan, Masters, Valerie Barbier, Masters, Ingrid G Winkler, PhD

Blood (2018) 132 (Supplement 1): 2575.

https://doi.org/10.1182/blood-2018-99-115869

Published: 2018

Journal Articles

Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)

Dominique Farge, PhD MD, John A Snowden, MD PhD, Manuela Badoglio, Myriam Labopin, MD, Hans Ulrich Scherer, MD PhD, Nicoletta Del Papa, PhD MD, Lothar Kanz, Marc Schmalzing, MD, Thierry Martin, MD PhD, Montserrat Rovira, MD, Thomas Daikeler, MD PhD, Gregory Pugnet, MD PhD, Joerg Henes, MD PhD

Blood (2018) 132 (Supplement 1): 3431.

https://doi.org/10.1182/blood-2018-99-116602

Published: 2018

Journal Articles

Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong

Ka Lok Luke Chan, MBBS, MPH, MRCP, Vivien W M Mak, Kate F S Leung, Joyce H Y Kwong, Nelson C N Chan, Kelvin C K Cheng, Natalie P H Chan, Daniel H F Fong, Stephen C C Choy, Carmen K M Ng, Johnny K F Ma, Michael L G Wong, Margaret Ng, Harold K K Lee

Blood (2018) 132 (Supplement 1): 4900.

https://doi.org/10.1182/blood-2018-99-113487

Published: 2018

Journal Articles

Synergistic Platelet Inhibitory Effects of Riociguat and Nitric Oxide Are Decreased By Protein Binding

Yifeng WU, MD, Alan D Michelson, MD, Andrew L Frelinger, III, PhD

Blood (2018) 132 (Supplement 1): 4971.

https://doi.org/10.1182/blood-2018-99-117070

Published: 2018

Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2017) 130 (Supplement 1): 98.

https://doi.org/10.1182/blood.V130.Suppl_1.98.98

Published: 2017

Journal Articles

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Ali Alahmari, MD, Jeffrey H. Lipton, MD PhD, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 2880.

https://doi.org/10.1182/blood.V130.Suppl_1.2880.2880

Published: 2017

Journal Articles

Pulmonary Adverse Effects Associated with Tyrosine Kinase Inhibitor (TKI) Therapy in Patients with Chronic Myeloid Leukemia (CML)

Naveed Ali, MD, Jibran Durrani, MD, Mary Naglak, PhD, Jessica Berman, MD, Herbert Edward Auerbach, DO, Peter V. Pickens, MD

Blood (2017) 130 (Supplement 1): 5258.

https://doi.org/10.1182/blood.V130.Suppl_1.5258.5258

Published: 2017

Journal Articles

Next Generation Sequencing Is a Useful Tool for the Diagnosis of Congenital/Idiopathic Erythrocytoses

Francois Girodon, MD PhD, Fabrice Airaud, PhD, Garrec Céline, MD, Pacault Mathilde, Dumont Solenne, Ricordeau Ingrid, Bézieau Stéphane, MD PhD, Betty Gardie, PhD

Blood (2016) 128 (22): 2434.

https://doi.org/10.1182/blood.V128.22.2434.2434

Published: 2016

Journal Articles

Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leukemia Patients with Imatinib-Resistance or -Intolerance: Results from a 6-Year Follow-up of a Multicenter Phase II Study

Xiaojun Huang, Qian Jiang, MD, Jianda Hu, MD PhD, Jianyong Li, Jie Jin, MD PhD, Fanyi Meng, Zhixiang Shen, MD, Ting Liu, Depei Wu, MDPhD, Jianmin Wang, Jianxiang Wang

Blood (2016) 128 (22): 1928.

https://doi.org/10.1182/blood.V128.22.1928.1928

Published: 2016

Journal Articles

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Manuel Ayala, MD, Jacqueline Domínguez, NL, Iván Bonilla, MD

Blood (2016) 128 (22): 5430.

https://doi.org/10.1182/blood.V128.22.5430.5430

Published: 2016

Journal Articles

Liposomal Delivery of a Phosphodiesterase 5 Inhibitor Enhances Prostacyclin-Mediated Adenosine Triphosphate Release from Human Red Blood Cells

Elizabeth Bowles, Randy Sprague, MD, Nuran Ercal, MD PhD

Blood (2016) 128 (22): 4803.

https://doi.org/10.1182/blood.V128.22.4803.4803

Published: 2016

Journal Articles

Diffuse Myocardial Fibrosis Is a Common Feature of Sickle Cell Anemia That Is Associated with Diastolic Dysfunction and Restrictive Cardiac Physiology

Omar Niss, MD, Michael D. Taylor, MD, Robert Fleck, MD, Tarek Alsaied, MD, Jeffrey Towbin, MD, Punam Malik, MD, Charles T. Quinn, MD MS

Blood (2016) 128 (22): 8.

https://doi.org/10.1182/blood.V128.22.8.8

Published: 2016

Journal Articles

Large Granular Lymphocyte Infiltration in the Bone Marrow in Children and Young Adults May Suggest Primary Immune Deficiency

Mervi H Taskinen, MD PhD, Satu Mustjoki, MD PhD, Kirsi Jahnukainen, MD PhD, Luca Trotta, MSc, Timo Siitonen, MD PhD, Timo Hautala, MD PhD, Andrey Zavialov, PhD, Kaarina Heiskanen, MD PhD, Emma M Haapaniemi, MD PhD, Janna Saarela, MD PhD, Mikko Seppänen, MD PhD

Blood (2015) 126 (23): 1024.

https://doi.org/10.1182/blood.V126.23.1024.1024

Published: 2015

Journal Articles

Clinical Features of Chinese Patients with Paroxysmal Nocturnal Hemoglobinuria Diagnosed By FLAER

Jing Li, MD, Haiying Hua, MD, Weyi Shen, MD, Guangsheng He, MD, Huayuan Zhu, MD, Shuai Wang

Blood (2015) 126 (23): 4544.

https://doi.org/10.1182/blood.V126.23.4544.4544

Published: 2015

Journal Articles

Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Diep Calvin, Christopher M Hillis, MD FRCPC

Blood (2015) 126 (23): 4030.

https://doi.org/10.1182/blood.V126.23.4030.4030

Published: 2015

Journal Articles

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Dilek Keskin, MD, Selin Berk, MD, Isil Erdogan Oztunali, MD, Fevzi Firat Yalniz, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren Aydin, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2015) 126 (23): 4037.

https://doi.org/10.1182/blood.V126.23.4037.4037

Published: 2015

Journal Articles

Association Between Hyperhemolysis and Vascular Complications in Sickle Cell Disease Sub-Saharan African Patients

Marie Dubert, MD MSc, Dapa Aly Diallo, MD, Aissata Tollo, MD, Saliou Diop, Sr., MD MSc, Suzanne Belinga, MD, Ibrahima Sanogo, MD, Odette Guifo, MD, Guillaume Wamba, MD, Ibrahima Diagne, MD, Indou Deme LY, MD, Kouakou Boidy, MD, Gustave Koffi, MD, Ismael Kamara, MD, Youssouf Traore, MD, Lucile Offredo, MSc, Aymeric Menet, MD MSc, Xavier Jouven, MD PhD, Brigitte Ranque, MD PhD

Blood (2015) 126 (23): 72.

https://doi.org/10.1182/blood.V126.23.72.72

Published: 2015

Journal Articles

Angiotensin Blockage with Losartan Is Associated with Decreased Albuminuria and Stable Renal Function in Adults and Children with HbSS on Hydroxyurea

Marianne E. Yee, MD MSc, Peter A. Lane, MD, James R. Eckman, MD, Antonio Guasch, MD

Blood (2015) 126 (23): 2183.

https://doi.org/10.1182/blood.V126.23.2183.2183

Published: 2015

Journal Articles

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

Dong-Wook Kim, Charles S. Cleeland, PhD, Susanne Saussele, Loretta A. Williams, PhD APRN, Hesham Mohamed, Javier Pinilla-Ibarz, Elisabetta Abruzzese, MD

Blood (2015) 126 (23): 1575.

https://doi.org/10.1182/blood.V126.23.1575.1575

Published: 2015

NARROW

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy

Prostaglandin I 2 in the Endosteal Bone Marrow Niche As a Novel Regulator of Hematopoietic Stem Cells

Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)

Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong

Synergistic Platelet Inhibitory Effects of Riociguat and Nitric Oxide Are Decreased By Protein Binding

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Pulmonary Adverse Effects Associated with Tyrosine Kinase Inhibitor (TKI) Therapy in Patients with Chronic Myeloid Leukemia (CML)

Next Generation Sequencing Is a Useful Tool for the Diagnosis of Congenital/Idiopathic Erythrocytoses

Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leukemia Patients with Imatinib-Resistance or -Intolerance: Results from a 6-Year Follow-up of a Multicenter Phase II Study

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Liposomal Delivery of a Phosphodiesterase 5 Inhibitor Enhances Prostacyclin-Mediated Adenosine Triphosphate Release from Human Red Blood Cells

Diffuse Myocardial Fibrosis Is a Common Feature of Sickle Cell Anemia That Is Associated with Diastolic Dysfunction and Restrictive Cardiac Physiology

Large Granular Lymphocyte Infiltration in the Bone Marrow in Children and Young Adults May Suggest Primary Immune Deficiency

Clinical Features of Chinese Patients with Paroxysmal Nocturnal Hemoglobinuria Diagnosed By FLAER

Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Association Between Hyperhemolysis and Vascular Complications in Sickle Cell Disease Sub-Saharan African Patients

Angiotensin Blockage with Losartan Is Associated with Decreased Albuminuria and Stable Renal Function in Adults and Children with HbSS on Hydroxyurea

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only